Advertisement

Medicine taking behaviours of people with type 2 diabetes in Indonesia: a qualitative study

  • Anna Wahyuni WidayantiEmail author
  • Pauline Norris
  • Susan Heydon
  • James A. Green
Research Article

Abstract

Background Medicine-taking behaviour of people in Indonesia is particularly complex because of Indonesia’s pluralistic health system, in which public and private medical services co-exist with traditional and alternative treatments. Objective This study aimed to explore medicine-taking behaviours of people with type 2 diabetes in Indonesia. Setting Rural and urban communities in East Nusa Tenggara and West Sumatera Provinces. Method Qualitative study with focus group discussions. Six focus groups, involving 45 diabetes patients, were conducted. The discussions were recorded and transcribed verbatim in the original language. The transcripts were translated into English and analysed for common themes. Main outcome measure People’s medicine-taking behaviours after being diagnosed with diabetes. Results Medicine-taking behaviours of diabetes participants aligned with the concept of resistance to medicine taking and a therapeutic decision model. It varied based on individual lay evaluation processes. After being diagnosed, participants commonly took the prescribed medicines for some period. They then self-evaluated the effectiveness of the prescribed medicines. Based on the self-evaluation, patients either continued to take the prescribed medicines or made a variety of changes: they discontinued taking the prescribed medicines, combined or alternated prescribed medicines with traditional medicines, or occasionally took medicines they bought without prescription. Reasons mentioned by participants for choosing traditional medicines including perceived ineffectiveness or side effect of the prescribed-medicines. Long-term medicine taking burdened the participants as the notion of being fed up with taking medicines was frequently mentioned. Problems of inaccessibility of the prescribed-medicines also emerged. Conclusion Diabetes patients’ medicine-taking behaviours and their reasons for decision-making need to be acknowledged to improve adherence to medicine. Health professionals should assist patients on how to evaluate effectiveness, manage side effects, and reduce the medicine-related burden.

Keywords

Focus groups Indonesia Medication adherence Medicine taking behaviour Qualitative study Traditional medicines Type 2 diabetes 

Notes

Acknowledgements

This work was supported by New Zealand ASEAN Scholars Awards, and was undertaken within the School of Pharmacy, University of Otago. The authors wish to acknowledge the participants, the health professionals in Puskesmas in study locations, research assistants, and translators.

Funding

There was no specific funding source for this study.

Conflicts of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    World Health Organization. Diabetes country profile 2016—Indonesia. World Health Organization. 2016. https://www.who.int/diabetes/country-profiles/idn_en.pdf?ua=1. Accessed 2 May 2018.
  2. 2.
    International Diabetes Federation. IDF Diabetes Atlas—Eighth edition 2017. 8th ed. International Diabetes Federation; 2017.Google Scholar
  3. 3.
    Soewondo P, Soegondo S, Suastika K, Pranoto A, Soeatmadji DW, Tjokroprawiro A. The DiabCare Asia 2008 study—outcomes on control and complications of type 2 diabetic patients in Indonesia. Med J Indones. 2010;19(4):235–44.CrossRefGoogle Scholar
  4. 4.
    Wibowo Y, Parsons R, Sunderland B, Hughes J. An evaluation of community pharmacy-based services for type 2 diabetes in an Indonesian setting: patient survey. PeerJ. 2015;3:e1449.PubMedPubMedCentralCrossRefGoogle Scholar
  5. 5.
    Radji M, Putri CS, Fauziyah S. Antibiotic therapy for diabetic foot infections in a tertiary care hospital in Jakarta, Indonesia. Diabetes Metab Syndr Clin Res Rev. 2014;8(4):221–4.CrossRefGoogle Scholar
  6. 6.
    Pemayun TGD, Naibaho RM. Clinical profile and outcome of diabetic foot ulcer, a view from tertiary care hospital in Semarang, Indonesia. Diabet Foot Ankle. 2017;8(1):1312974.PubMedPubMedCentralCrossRefGoogle Scholar
  7. 7.
    Yusuf S, Okuwa M, Irwan M, Rassa S, Laitung B, Thalib A, et al. Prevalence and risk factor of diabetic foot ulcers in a regional hospital, Eastern Indonesia. Open J Nurs. 2016;6:1–10.CrossRefGoogle Scholar
  8. 8.
    Soegondo S, Prodjosudjadi W, Setiawati A. Prevalence and risk factors for microalbuminuria in a cross-sectional study of type-2 diabetic patients in Indonesia: a subset of DEMAND study. Med J Indones. 2009;18(2):124–30.CrossRefGoogle Scholar
  9. 9.
    Egede LE, Gebregziabher M, Echols C, Lynch CP. Longitudinal effects of medication nonadherence on glycemic control. Ann Pharmacother. 2014;48(5):562–70.PubMedCrossRefPubMedCentralGoogle Scholar
  10. 10.
    Krapek K, King K, Warren SS, George KG, Caputo DA, Mihelich K, et al. Medication adherence and associated hemoglobin A1c in type 2 diabetes. Ann Pharmacother. 2004;38(9):1357–62.PubMedCrossRefPubMedCentralGoogle Scholar
  11. 11.
    Krass I, Schieback P, Dhippayom T. Adherence to diabetes medication: a systematic review. Diabet Med. 2015;32(6):725–37.PubMedCrossRefPubMedCentralGoogle Scholar
  12. 12.
    Alfian SD, Sukandar H, Lestari K, Abdulah R. Medication adherence contributes to an improved quality of life in type 2 diabetes mellitus patients: a cross-sectional study. Diabetes Ther. 2016;7(4):755–64.PubMedPubMedCentralCrossRefGoogle Scholar
  13. 13.
    Alfian SD, Sukandar H, Arisanti N, Abdulah R. Complementary and alternative medicine use decreases adherence to prescribed medication in diabetes patients. Ann Trop Med Public Health. 2016;9(3):174–9.CrossRefGoogle Scholar
  14. 14.
    McSharry J, McGowan L, Farmer AJ, French DP. Perceptions and experiences of taking oral medications for the treatment of Type 2 diabetes mellitus: a systematic review and meta-synthesis of qualitative studies. Diabet Med. 2016;33(10):1330–8.PubMedCrossRefGoogle Scholar
  15. 15.
    Sapkota S, Brien JAE, Aslani P. Nepalese patients’ perceptions of treatment modalities for type 2 diabetes. Patient Prefer Adherence. 2016;10:1777–86.PubMedPubMedCentralCrossRefGoogle Scholar
  16. 16.
    Sapkota S, Brien JAE, Aslani P. Nepalese patients’ anti-diabetic medication taking behaviour: an exploratory study. Ethn Health. 2018;23(7):718–36.PubMedCrossRefGoogle Scholar
  17. 17.
    Kumar K, Greenfield S, Raza K, Gill P, Stack R. Understanding adherence-related beliefs about medicine amongst patients of South Asian origin with diabetes and cardiovascular disease patients: a qualitative synthesis. BMC Endocr Disord. 2016;16(1):24.PubMedPubMedCentralCrossRefGoogle Scholar
  18. 18.
    Pagès-Puigdemont N, Mangues MA, Masip M, Gabriele G, Fernández-Maldonado L, Blancafort S, et al. Patients’ perspective of medication adherence in chronic conditions: a qualitative study. Adv Ther. 2016;33(10):1740–54.PubMedPubMedCentralCrossRefGoogle Scholar
  19. 19.
    Bourgeault I, Dingwall R, Vries RD. The SAGE handbook of qualitative methods in health research. London: SAGE Publications; 2010.CrossRefGoogle Scholar
  20. 20.
    Parthan A, Vincze G, Morisky DE, Khan ZM. Strategies to improve adherence with medications in chronic, ‘silent’ diseases representing high cardiovascular risk. Expert Rev Pharmacoecon Outcomes Res. 2006;6(3):325–36.PubMedCrossRefPubMedCentralGoogle Scholar
  21. 21.
    Patton MQ. Qualitative research & evaluation methods. 3rd ed. California: Sage Publication, Inc.; 2002.Google Scholar
  22. 22.
    Statistics Indonesia. Per Capita Gross Regional Domestic Product by Province. Statistics Indonesia, Jakarta. https://www.bps.go.id/linkTableDinamis/view/id/957. Accessed 17 May 2017.
  23. 23.
    Statistics Indonesia. Klasifikasi Perkotaan dan Pedesaan di Indonesia: Buku 1 Sumatera [Classification of urban and rural areas in Indonesia: Book 1 Sumatera]. Jakarta: Statistics Indonesia; 2010.Google Scholar
  24. 24.
    Statistics Indonesia. Klasifikasi Perkotaan dan Pedesaan di Indonesia: Buku 3 Bali, Nusa Tenggara, Kalimantan Sulawesi, Maluku, dan Papua [Classification of urban and rural areas in Indonesia: Book 3 Bali, Nusa Tenggara, Kalimantan Sulawesi, Maluku, and Papua]. Jakarta: Statistics Indonesia; 2010.Google Scholar
  25. 25.
    Elo S, Kyngäs H. The qualitative content analysis process. J Adv Nurs. 2008;62(1):107–15.PubMedCrossRefPubMedCentralGoogle Scholar
  26. 26.
    Pound P, Britten N, Morgan M, Yardley L, Pope C, Daker-White G, et al. Resisting medicines: a synthesis of qualitative studies of medicine taking. Soc Sci Med. 2005;61(1):133–55.PubMedCrossRefPubMedCentralGoogle Scholar
  27. 27.
    Dowell J, Hudson H. A qualitative study of medication-taking behaviour in primary care. Fam Pract. 1997;14(5):369–75.PubMedCrossRefPubMedCentralGoogle Scholar
  28. 28.
    Buda R, Elsayed-Elkhouly SM. Cultural differences between Arabs and Americans: individualism-collectivism revisited. J Cross Cult Psychol. 1998;29(3):487–92.CrossRefGoogle Scholar
  29. 29.
    McLaughlin LA, Braun KL. Asian and Pacific Islander cultural values: considerations for health care decision making. Health Soc Work. 1998;23(2):116–26.PubMedCrossRefPubMedCentralGoogle Scholar
  30. 30.
    Alzubaidi H, Mc Mamara K, Chapman C, Stevenson V, Marriott J. Medicine-taking experiences and associated factors: comparison between Arabic-speaking and Caucasian english-speaking patients with type 2 diabetes. Diabet Med. 2015;32(12):1625–33.PubMedCrossRefPubMedCentralGoogle Scholar
  31. 31.
    Chang HYA, Wallis M, Tiralongo E, Wang HL. Decision-making related to complementary and alternative medicine use by people with type 2 diabetes: a qualitative study. J Clin Nurs. 2012;21(21–22):3205–15.PubMedCrossRefPubMedCentralGoogle Scholar
  32. 32.
    Mohammed MA, Moles RJ, Chen TF. Medication-related burden and patients’ lived experience with medicine: a systematic review and metasynthesis of qualitative studies. BMJ Open. 2016;6(2):e010035.PubMedPubMedCentralCrossRefGoogle Scholar
  33. 33.
    Krska J, Morecroft CW, Poole H, Rowe PH. Issues potentially affecting quality of life arising from long-term medicines use: a qualitative study. Int J Clin Pharm. 2013;35(6):1161–9.PubMedCrossRefPubMedCentralGoogle Scholar
  34. 34.
    Suswardany DL, Sibbritt DW, Supardi S, Pardosi JF, Chang S, Adams J. A cross-sectional analysis of traditional medicine use for malaria alongside free antimalarial drugs treatment amongst adults in high-risk malaria endemic provinces of Indonesia. PLoS ONE. 2017;12(3):e0173522.PubMedPubMedCentralCrossRefGoogle Scholar
  35. 35.
    Murhandarwati EEH, Fuad A, Nugraheni MDF, Sulistyawati, Wijayanti MA, Widartono BS, et al. Early malaria resurgence in pre-elimination areas in Kokap Subdistrict, Kulon Progo, Indonesia. Malar J. 2014;13:130.PubMedPubMedCentralCrossRefGoogle Scholar
  36. 36.
    Peters RMH, Dadun LM, Miranda-Galarza B, Van Brakel WH, Zweekhorst MBM, et al. The meaning of leprosy and everyday experiences: An exploration in Cirebon, Indonesia. J Trop Med. 2013;2013:507034.PubMedPubMedCentralCrossRefGoogle Scholar
  37. 37.
    Santoso SS, Prasodjo R, Zalbawi S. Faktor faktor yang mendorong penderita hipertensi ke pengobatan tradisional di DKI Jakarta, Yogyakarta, dan Surabaya [Factors influencing hypertension patients seeking care from traditional and alternative therapies: a study in Jakarta, Yogyakarta, and Surabaya]. Media Penelit Pengemb Kesehat. 2001;11(1 Mar).Google Scholar
  38. 38.
    Santoso SS, Waluyo I, Kasnodiharjo K. Profil penderita diabetes melitus yang berobat ke pengobat tradisional di DKI Jakarta, DI Yogyakarta, dan Surabaya [Profile of diabetes mellitus patients who sought care from traditional and alternative therapies: a study in Jakarta, Yogyakarta, and Surabaya]. Bul Penelit Kesehat. 1999;27(3&4 Des).Google Scholar
  39. 39.
    Aikins Ad-G. Healer shopping in Africa: new evidence from rural-urban qualitative study of Ghanaian diabetes experiences. BMJ. 2005;331(7519):737–42.CrossRefGoogle Scholar
  40. 40.
    Suparee N, McGee P, Khan S, Pinyopasakul W. Life-long battle: perceptions of type 2 diabetes in Thailand. Chronic Illn. 2015;11(1):56–68.PubMedCrossRefPubMedCentralGoogle Scholar
  41. 41.
    Mendenhall E, McMurry HS, Shivashankar R, Narayan KMV, Tandon N, Prabhakaran D. Normalizing diabetes in Delhi: a qualitative study of health and health care. Anthropol Med. 2016;23(3):295–310.PubMedPubMedCentralCrossRefGoogle Scholar
  42. 42.
    Lundberg PC, Thrakul S. Type 2 diabetes: How do Thai Buddhist people with diabetes practise self-management? J Adv Nurs. 2012;68(3):550–8.PubMedCrossRefPubMedCentralGoogle Scholar
  43. 43.
    Amarasekara AATD, Fongkaew W, Turale S, Wimalasekara SW, Chanprasit C. An ethnographic study of diabetes health beliefs and practices in Sri Lankan adults. Int Nurs Rev. 2014;61(4):507–14.PubMedCrossRefPubMedCentralGoogle Scholar
  44. 44.
    Iskandarsyah A, de Klerk C, Suardi DR, Soemitro MP, Sadarjoen SS, Passchier J. Psychosocial and cultural reasons for delay in seeking help and nonadherence to treatment in Indonesian women with breast cancer: a qualitative study. Health Psychol. 2014;33(3):214–21.PubMedCrossRefPubMedCentralGoogle Scholar
  45. 45.
    World Health Organization. Traditional medicine—growing needs and potential. WHO Policy Pespective on Medicines. Geneva: World Health Organization; 2002.Google Scholar
  46. 46.
    Elfahmi WHJ, Kayser O. Jamu: Indonesian traditional herbal medicine towards rational phytopharmacological use. J Herb Med. 2014;4(2):51–73.CrossRefGoogle Scholar
  47. 47.
    Heydon S. Which medicine? Medicine-taking and changing Sherpa lives. Himalaya J Assoc Nepal Himal Stud. 2015;35(1):9.Google Scholar
  48. 48.
    Seeberg J, Pannarunothai S, Padmawati RS, Trisnantoro L, Barua N, Pandav CS. Treatment seeking and health financing in selected poor urban neighbourhoods in India, Indonesia and Thailand. Soc Sci Med. 2014;102:49–57.PubMedCrossRefPubMedCentralGoogle Scholar
  49. 49.
    Utarini A, Winkvist A, Ulfa FM. Rapid assessment procedures of malaria in low endemic countries: community perceptions in Jepara district, Indonesia. Soc Sci Med. 2003;56(4):701–12.PubMedCrossRefPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.School of PharmacyUniversity of OtagoDunedinNew Zealand
  2. 2.Faculty of PharmacyUniversitas Gadjah MadaYogyakartaIndonesia
  3. 3.School of Allied Health and Physical Activity for Health ClusterUniversity of LimerickLimerickIreland
  4. 4.Health Research Institute (HRI)University of LimerickLimerickIreland

Personalised recommendations